It’s been years since AI proponents started promising big returns on healthcare providers’ investments in the technology. The results have yet to catch up with the pitches. What’s the holdup? 

As these models continue to advance, it is important to understand how their performance holds up over time.

Software engineer and CEO Shiva Suri says he got the idea for New Lantern after watching his radiologist mother bogged down by administrative tasks. 

Ultromics designed EchoGo Amyloidosis to evaluate routine echocardiogram results for signs of cardiac amyloidosis. It received the FDA's breakthrough device designation back in 2023.

Medtronic has launched new research into AI's potential to identify patients with severe aortic stenosis and other worrying symptoms. The company hopes to overcome longstanding health disparities and reach individuals who may otherwise go untreated.

“When we rely too much on whatever the computer tells us, that’s a problem."

By expediting communication between radiologists and referring providers when suspicious findings are identified, the system has great potential to improve clinical outcomes in real-world scenarios, authors of a new study in JACR suggest.

Black-box outputs aren’t just a problem with AI. They’re also a problem with physicians.